180 related articles for article (PubMed ID: 36848915)
1. Mechanisms of ageing: growth hormone, dietary restriction, and metformin.
Khan J; Pernicova I; Nisar K; Korbonits M
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):261-281. PubMed ID: 36848915
[TBL] [Abstract][Full Text] [Related]
2. Metformin: do we finally have an anti-aging drug?
Anisimov VN
Cell Cycle; 2013 Nov; 12(22):3483-9. PubMed ID: 24189526
[TBL] [Abstract][Full Text] [Related]
3. Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age.
Duran-Ortiz S; List EO; Basu R; Kopchick JJ
Pituitary; 2021 Jun; 24(3):438-456. PubMed ID: 33459974
[TBL] [Abstract][Full Text] [Related]
4. Ageing, growth hormone and physical performance.
Lanfranco F; Gianotti L; Giordano R; Pellegrino M; Maccario M; Arvat E
J Endocrinol Invest; 2003 Sep; 26(9):861-72. PubMed ID: 14964439
[TBL] [Abstract][Full Text] [Related]
5. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
[TBL] [Abstract][Full Text] [Related]
6. The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing.
Sonntag WE; Lynch C; Thornton P; Khan A; Bennett S; Ingram R
J Anat; 2000 Nov; 197 Pt 4(Pt 4):575-85. PubMed ID: 11197531
[TBL] [Abstract][Full Text] [Related]
7. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing.
D'Costa AP; Ingram RL; Lenham JE; Sonntag WE
J Reprod Fertil Suppl; 1993; 46():87-98. PubMed ID: 8315618
[TBL] [Abstract][Full Text] [Related]
8. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.
Berryman DE; Christiansen JS; Johannsson G; Thorner MO; Kopchick JJ
Growth Horm IGF Res; 2008 Dec; 18(6):455-71. PubMed ID: 18710818
[TBL] [Abstract][Full Text] [Related]
9. Targeting ageing and preventing organ degeneration with metformin.
Sunjaya AP; Sunjaya AF
Diabetes Metab; 2021 Feb; 47(1):101203. PubMed ID: 33148437
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
11. Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion.
Ruiz-Torres A; Soares de Melo Kirzner M
Gerontology; 2002; 48(6):401-7. PubMed ID: 12393957
[TBL] [Abstract][Full Text] [Related]
12. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.
Phoenix KN; Vumbaca F; Fox MM; Evans R; Claffey KP
Breast Cancer Res Treat; 2010 Sep; 123(2):333-44. PubMed ID: 20204498
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Berker B; Emral R; Demirel C; Corapcioglu D; Unlu C; Kose K
Gynecol Endocrinol; 2004 Sep; 19(3):125-33. PubMed ID: 15697073
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.
De Leo V; La Marca A; Orvieto R; Morgante G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1598-600. PubMed ID: 10770203
[TBL] [Abstract][Full Text] [Related]
16. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction.
Shimokawa I; Higami Y; Tsuchiya T; Otani H; Komatsu T; Chiba T; Yamaza H
FASEB J; 2003 Jun; 17(9):1108-9. PubMed ID: 12692087
[TBL] [Abstract][Full Text] [Related]
17. The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically.
Bergamini E; Cavallini G; Donati A; Gori Z
Biomed Pharmacother; 2003; 57(5-6):203-8. PubMed ID: 12888255
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients.
Teti C; Talco M; Albertelli M; Albanese V; Minuto M; Aglialoro A; Monachesi M; Viviani G; Gatto F; Ferone D; Boschetti M
J Endocrinol Invest; 2020 Mar; 43(3):389-393. PubMed ID: 31473983
[TBL] [Abstract][Full Text] [Related]
19. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
Lee KO; Liao L; Mukherjee JJ
Mech Ageing Dev; 2004 Apr; 125(4):291-5. PubMed ID: 15063105
[TBL] [Abstract][Full Text] [Related]
20. Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones.
Barzilai N; Bartke A
J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):187-91. PubMed ID: 19228789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
